← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Kiromic, Inc.
Houston, TX
$1,299,900
Total funding
3
Grants
Funding over time
peak $852.5K · FY2014–18$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,299,900 · 3
By mechanism
R42$850,531 · 1
R41$449,369 · 2
Investigators at Kiromic, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development and non-clinical GLP testing of a new anti-arteriosclerosis gene therapy delivered by engineered adeno-associated viral vectors.$850,531
R42 · FY2018 · HL
Microparticulate mucosal vaccine for triple-negative breast cancer$224,522
R41 · FY2017 · CA
Ovarian cancer using novel nanoparticle formulations$121,003
R41 · FY2014 · CA
Ovarian cancer using novel nanoparticle formulations$101,844
R41 · FY2015 · CA
Microparticulate mucosal vaccine for triple-negative breast cancer$2,000
R41 · FY2018 · CA